ALT - Altimmune, Inc.

Insider activity in ALT over the last quarter tilts toward buying: insiders added a net 15,000 shares worth roughly $44K.

Classified under Biotechnology (Health Care sector), ALT's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Garg Vipin K	424.5K	$1.30M	-
Other	Roberts M Scot	113.7K	$274.5K	-
Other	Jordt Raymond M	70.1K	$215.2K	-
CEO	Durso Jerome Benedict	62.5K	$184.4K	-
CFO	Weaver Gregory L	49.9K	$137.8K	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 13, 2026	Durso Jerome Benedict	President and CEO	Buy	15,000	$2.95	$44,250.00	+31.6%	-	-
Apr 6, 2026	Gill John	Director	Buy	9,200	$3.41	$31,349.92	+73.6%	-7.5%	-
Apr 1, 2026	Durso Jerome Benedict	President and CEO	Buy	15,000	$3.14	$47,100.00	+46.2%	-2.6%	-
Apr 1, 2026	Weaver Gregory L	Chief Financial Officer	Buy	10,000	$3.15	$31,499.00	+35.6%	-2.6%	-
Mar 6, 2026	Durso Jerome Benedict	President and CEO	Buy	20,000	$3.54	$70,790.00	+160.0%	-17.5%	-
Mar 6, 2026	Weaver Gregory L	Chief Financial Officer	Buy	5,000	$3.54	$17,700.00	+21.7%	-17.5%	-
Jan 8, 2026	Pisano Wayne67	Director	Buy	5,000	$4.08	$20,410.00	+58.8%	-17.4%	-
Jan 5, 2026	Sohn Catherine A.55	Director	Buy	500	$4.24	$2,117.55	+50.0%	-18.6%	-
Dec 29, 2025	Jorkasky Diane	Director	Buy	527	$3.80	$2,002.60	New	-21.7%	-
Dec 23, 2025	Gill John	Director	Buy	12,500	$4.10	$51,250.00	New	-14.0%	-